公司資料
Stoke Therapeutics 股價、新聞與催化劑
- 股票代碼:
- STOK
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
32.29 USD (+2.83%)
收盤價
最後更新: 2026年8月21日
1.79B USD
市值
股價為何變動
As of Aug 21, 2026, STOK closed up 2.83% at $32.29. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Stoke Therapeutics is a genetic-medicine company focused on RNA-based approaches for severe diseases such as epilepsy. Its platform is aimed at restoring protein expression in haploinsufficient conditions.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Stoke sits in specialty biotechnology.
商業模式特徵
The company depends on clinical proof, RNA platform validation, and the ability to translate genetic medicine into real value.
生技產業定位
Stoke is a high-beta genetic-medicine name whose valuation is closely tied to clinical progress.
未來催化劑
- Stoke Therapeutics's catalysts are zorevunersen in Dravet syndrome and its SYNGAP1 program. The next update matters because the company’s neuroscience story is still very focused.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。